SMART Trial: Community Stigma Reduction

NCT05075330 | Completed

• 1 other identifier: 21-08181-XP
• Study Type: interventional
• Target: 199
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this project is to engage community members from two low-income African American communities (N=200) in a survey study that assesses stigma toward those with Opioid Use Disorder (OUD). Those from the intervention community will be subject to a stigma reduction campaign via billboards. Those from the control community will not. Stigma will be re-assessed following the period of the campaign.

Conditions

Opioid-use Disorder; Stigma, Social

Keywords

stigma; opioid use disorder; community

Outcome Measures

Primary Outcomes (1)

• Stigma score

  Pre- and post-intervention stigma assessments using the Exposure to Drug Users Index, Drug Use Stigmatization Scale, and the Stigma of Drug Users Scale

  Change from baseline stigma score at 8 weeks

Study Arms (2)

Intervention

EXPERIMENTAL

Participants who live in the Orange Mound community of Memphis. Billboards targeting stigma reduction were posted in the community for one month.

Behavioral: Opioid Use Disorder Stigma Reduction

Control

NO INTERVENTION

Participants who live in the Frayser community of Memphis. No billboards (intervention) were placed here.

Interventions

Opioid Use Disorder Stigma Reduction BEHAVIORAL

Billboards with destigmatizing language regarding opioid use disorder placed in the community.

Intervention

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Identify as African American or Mixed race
• Reside in Frayser or Orange Mound Communities
• Access to telephone for follow-up assessment

You may not qualify if:

• Unable to understand consent procedures

Sponsors & Collaborators

• Karen Derefinko, PhD: lead
• National Center for Complementary and Integrative Health (NCCIH): collaborator

Study Sites (1)

University of Tennessee Health Science Center

Memphis, Tennessee, 38163, United States

Location

MeSH Terms

Conditions

Opioid-Related Disorders; Social Stigma

Condition Hierarchy (Ancestors)

Narcotic-Related Disorders; Substance-Related Disorders; Chemically-Induced Disorders; Mental Disorders; Social Behavior; Behavior

Study Officials

• Karen Derefinko, PhD

  University of Tennessee

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Associate Professor

Model Details: Participants assigned to intervention or control based on zip code of primary residence.

Study Record Dates

• First Submitted: September 14, 2021
• First Posted: October 12, 2021
• Study Start: June 16, 2021
• Primary Completion: August 19, 2021
• Study Completion: August 19, 2021
• Last Updated: March 18, 2022

Record last verified: 2022-03

Data Sharing

• IPD Sharing: Will share
• Time Frame: Available by end of 2021.

Locations

US (1)